Session 1 of Young Investigator Symposium
9 October 2024
A PVRI 2024 Digital webinar
9 October 2024, 3pm BST
The Young Investigators Series aims to showcase the groundbreaking research being done by clinicians and scientists that are early in their careers. Sessions will be divided to focus on clinical research or basic science translational research. The PVRI Leadership has the goal to be inclusive, to support, and to highlight the work being done by individuals in the pulmonary vascular research field, including its newest and youngest members.
Presentations
- Cellular mechosignaling in pulmonary arterial hypertension Daniela Valdez-Jasso, University of California, San Diego, La Jolla, CA
- Sex differences in pulmonary arterial hypertension randomized clinical trials Jasleen Minhas, University of Pennsylvania, Philadelphia, PA
- Precapillary pulmonary hypertension and death from COVID-19 George Alba, Massachusetts General Hospital, Boston, MA
- Molecular pathways in right ventricular failure - the role of apelin Andrea Frump, Indiana University Bloomington, IN
- Prostacyclin reverses right ventricular hypertrophy and dysfunction in severe PAH Rebecca Vanderpool, Ohio State University, Columbus, OH
- Pulmonary vascular complications of heart failure with preserved ejection fraction Yen-Chun (Charly) Lai, Indiana University, Bloomington, IN
Moderated by Soni Pullamsetti, Max Planck Institute and Harm Jan Bogaard, University Medical Center
Speakers & moderators
Daniela Valdez-Jasso, University of California, USA
Jasleen Minhas, University of Pennsylvania, USA
George Alba, Massachusetts General Hospital, USA
Andrea Frump, , Indiana University Bloomington, USA
Rebecca Vanderpool, Ohio State University, USA
Yen-Chun (Charly) Lai, Indiana University, USA
Soni Pullamsetti, Max Planck Institute, Germany
Harm Jan Bogaard, University Medical Center, Netherlands
Additional comments are available to members. Login or register to become a member today
RegisterorLogin to view